Fabry disease: open trials in Japan

• NCT06904261

  A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

  Trial Treatment · Phase 3 · Amicus Therapeutics

  Kitasato University Hospital, Sagamihara

  Registry updated 2026-10-22

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  Chiba · Kobe · Nankoku · Niigata · Osaka · Tokyo

  Registry updated 2026-10-14

• NCT05710692

  Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease

  Trial Treatment · Phase 2/3 · Chiesi Farmaceutici S.p.A.

  Asahikawa Medical University Hospital, Asahikawa · Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Bunkyo-ku · Fukuoka University Chikushi Hospital, Chikushino-shi · Tokyo Jikei University Hospital, Minato-ku · Niigata University Medical & Dental Hospital, Niigata · University of the Ryukyu Hospital, Nishihara · National Hospital Organization Okayama Medical Center, Okayama · Tohoku University Hospital, Sendai · Keio University Hospital, Shinjuku-ku · Osaka University Hospital, Suita

  Registry updated 2026-03-18

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error